Nanoparticle Drug
Showing 1 - 25 of >10,000
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +4 more
- BET Bromodomain Inhibitor ZEN-3694
- +3 more
- (no location specified)
Jun 28, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker
Suspended
- Recurrent Aggressive Non-Hodgkin Lymphoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan
Active, not recruiting
- Childhood Solid Neoplasm
- +4 more
- Irinotecan Hydrochloride
- +4 more
-
Birmingham, Alabama
- +20 more
Feb 1, 2023
Breast Cancer Trial in Duarte, Pasadena (drug, other, procedure)
Active, not recruiting
- Breast Cancer
- paclitaxel albumin-stabilized nanoparticle formulation
- +6 more
-
Duarte, California
- +1 more
Jan 31, 2023
Bone Loss in Jaw Trial in Mansoura (Melatonin gel, Metformin and melatonin gel, gel)
Enrolling by invitation
- Bone Loss in Jaw
- Melatonin gel
- +3 more
-
Mansoura, Dakhlia, EgyptAmira R agab AL-agooz
Jun 13, 2023
Magnetic Resonance Imaging Trial in Xinxiang (polysaccharide superparamagnetic iron oxide injection)
Completed
- Magnetic Resonance Imaging
- polysaccharide superparamagnetic iron oxide injection
-
Xinxiang, Henan, ChinaXinxiang Central Hospital
Aug 23, 2023
Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle
Recruiting
- Advanced Soft Tissue Sarcoma
- +2 more
- Nanoparticle Albumin-Bound Rapamycin
- Pazopanib hydrochloride
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)
Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)
Recruiting
- Advanced Solid Tumor
- +8 more
- CNSI-Fe(II) 30 mg
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Sep 15, 2023
Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)
Recruiting
- Human Immunodeficiency Virus
- +2 more
-
Seattle, WashingtonUW Positve Research, Harborview Medical Center
May 8, 2023
Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- Prostate Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2022
Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,
Completed
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Carcinoma
- Fluorouracil
- +5 more
-
Birmingham, Alabama
- +806 more
Oct 18, 2022
Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)
Completed
- Multiple Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7
Completed
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7
- +8 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2022
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena
Active, not recruiting
- HER2-positive Breast Cancer
- +9 more
- pertuzumab
- +3 more
-
Duarte, California
- +2 more
Mar 17, 2022
Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)
Not yet recruiting
- Gastric Cancer
- Small-cell Lung Cancer
- EP0057
- Olaparib tablets
-
Shanghai, Changning District, 交通大学 邮政编码, China
- +20 more
Nov 1, 2022
Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in United States
Active, not recruiting
- Pancreatic Adenocarcinoma
- +3 more
- Gemcitabine Hydrochloride
- +5 more
-
Duarte, California
- +3 more
Mar 17, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced
Completed
- Diffuse Intrinsic Pontine Glioma
- Panobinostat Nanoparticle Formulation MTX110
- Convection-Enhanced Delivery (CED)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 2, 2022
Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus
Not yet recruiting
- Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
- NAB-Paclitaxel plus Cisplatin
- Cisplatin plus Epirubicin plus Cyclophosphamide
-
Shanghai, Shanghai, ChinaYian Zhang
Apr 17, 2023